Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal Cancer.
Saved in:
| Title: | Results of the Phase I/II Study and Preliminary B-cell Gene Signature of Combined Inhibition of Glutamine Metabolism and EGFR in Colorectal Cancer. |
|---|---|
| Authors: | Ciombor KK; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Bae SW; Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas., Whisenant JG; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Ayers GD; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee., Sheng Q; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee., Peterson TE; Vanderbilt University Institute of Imaging Science, Vanderbilt University Medical Center, Nashville, Tennessee.; Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, Tennessee., Smith GT; Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, Tennessee., Lin K; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Chowdhury S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kanikarla Marie P; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sorokin A; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Cohen AS; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri., Goff LW; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Cardin DB; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Shen JP; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kopetz S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Eng C; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Shyr Y; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee., Berlin J; Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Manning HC; Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas. |
| Source: | Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2025 Apr 14; Vol. 31 (8), pp. 1437-1448. |
| Publication Type: | Journal Article; Clinical Trial, Phase II; Clinical Trial, Phase I |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
